Kissei Aims for 40% Market Share for Epoetin Alfa at Early Stage

Masaki Morozumi, Director of Sales & Marketing Division In an interview with Jiho, Masaki Morozumi, managing director and director of Sales & Marketing Division at Kissei Pharmaceutical said the sales of the company’s biosimilar for renal anemia Epoetin Alfa BS...read more